A Luciferase-Reporter Gene-Expressing T-Cell Line Facilitates Neutralization and Drug-Sensitivity Assays That Use Either R5 or X4 Strains of Human Immunodeficiency Virus Type 1
- 15 February 2001
- Vol. 280 (2) , 292-300
- https://doi.org/10.1006/viro.2000.0780
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Effect of Highly Active Antiretroviral Therapy on Binding and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2000
- LuSIV Cells: A Reporter Cell Line for the Detection and Quantitation of a Single Cycle of HIV and SIV ReplicationVirology, 2000
- Primary Isolate Neutralization by HIV Type 1-Infected Patient Sera in the Era of Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 1999
- HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyJournal of Clinical Investigation, 1999
- Toward an HIV Type 1 Vaccine that Generates Potent, Broadly Cross-Reactive Neutralizing AntibodiesAIDS Research and Human Retroviruses, 1999
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- Indicator Cell Lines for Detection of Primary Strains of Human and Simian Immunodeficiency VirusesVirology, 1997
- Detection of HIV-1 Infection with a Green Fluorescent Protein Reporter SystemJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal AntibodyScience, 1994
- Antigen Detection Is a Reliable Method for Evaluating HIV/SIV Neutralization AssaysAIDS Research and Human Retroviruses, 1993